ELUCIDATION OF CATALYTIC SPECIFICITIES OF HUMAN CYTOCHROME-P450 AND GLUTATHIONE-S-TRANSFERASE ENZYMES AND RELEVANCE TO MOLECULAR EPIDEMIOLOGY

被引:45
作者
GUENGERICH, FP
SHIMADA, T
RANEY, KD
YUN, CH
MEYER, DJ
KETTERER, B
HARRIS, TM
GROOPMAN, JD
KADLUBAR, FF
机构
[1] VANDERBILT UNIV,MED CTR,SCH MED,CTR MOLEC TOXICOL,NASHVILLE,TN 37232
[2] VANDERBILT UNIV,SCH MED,CTR MOLEC TOXICOL,NASHVILLE,TN 37235
[3] VANDERBILT UNIV,SCH MED,DEPT CHEM,NASHVILLE,TN 37235
[4] UNIV LONDON MIDDLESEX HOSP,CRC,MOLEC TOXICOL RES GRP,LONDON W1P 6DB,ENGLAND
[5] JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT ENVIRONM HLTH SCI,DIV ENVIRONM CHEM,BALTIMORE,MD 21205
[6] NATL CTR TOXICOL RES,JEFFERSON,AR 72079
关键词
D O I
10.2307/3431250
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
A number of different approaches have been used to determine the catalytic selectivity of individual human enzymes toward procarcinogens. Studies with cytochrome P450 (P450) enzymes and glutathione S-transferases are summarized here, and recent work with pyrrolizidine alkaloids, aflatoxins, 4,4'-methylenebis(2-chloroaniline), and ethyl carbamate is discussed. In some cases a single enzyme can catalyze both activation and detoxication reactions of a chemical. The purification and characterization of human lung P4501A1 and the development of a noninvasive assay for human P4502E1 are also described.
引用
收藏
页码:75 / 80
页数:6
相关论文
共 28 条
[11]  
GUENGERICH FP, 1988, MOL PHARMACOL, V33, P500
[12]   MECHANISM-BASED INACTIVATION OF HUMAN LIVER MICROSOMAL CYTOCHROME-P-450-IIIA4 BY GESTODENE [J].
GUENGERICH, FP .
CHEMICAL RESEARCH IN TOXICOLOGY, 1990, 3 (04) :363-371
[13]  
GUENGERICH FP, 1991, J PHARMACOL EXP THER, V256, P1189
[14]   EFFECTS OF PHENOBARBITAL ON THE BILIARY-EXCRETION OF AFLATOXIN P1-GLUCURONIDE AND AFLATOXIN B1-S-GLUTATHIONE IN THE RAT [J].
HOLESKI, CJ ;
EATON, DL ;
MONROE, DH ;
BELLAMY, GM .
XENOBIOTICA, 1987, 17 (02) :139-153
[15]  
Jakoby W. B., 1980, ENZYMATIC BASIS DETO, V1, P1
[16]  
KENSLER TW, 1987, CANCER RES, V47, P4271
[17]  
KETTERER B, 1988, GLUTATHIONE CONJUGAT, P74
[18]  
KITADA M, 1990, CANCER RES, V50, P2641
[19]  
MEYER DJ, IN PRESS ANTICARCINO, V3
[20]  
MILLER EC, 1981, CANCER-AM CANCER SOC, V47, P2327, DOI 10.1002/1097-0142(19810515)47:10<2327::AID-CNCR2820471003>3.0.CO